14-day Premium Trial Subscription Sign Up For FreeGet Free

ContraVir Pharmaceuticals Inc Stock Forecast NASDAQ:CTRV

$1.01 (-3.81%)

Volume: 557k

Closed: Jan 21, 2022

Hollow Logo Score: -6.157

ContraVir Pharmaceuticals Inc Stock Forecast

$1.01 (-3.81%)

Volume: 557k

Closed: Jan 21, 2022

Score Hollow Logo -6.157
Which way will CTRV go? Request

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicates a upcoming change. Break up through the moving average line, or continuously movements above the moving average line indicates a break up, and vice versa downwards.

Source: http://www.bollingerbands.com

CTRV Stock Risk

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0499 between high and low, or 4.94%. For the last week, the stock has had a daily average volatility of 5.61%.

Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 36 and the stock is currently not being overbought or oversold

ContraVir Pharmaceuticals Inc stock price ended on $1.01 on Friday after losing 3.81%
(Updated on Jan 21, 2022)


Sell candidate since 2022-01-21 PDF

The ContraVir Pharmaceuticals Inc stock price fell by -3.81% on the last day (Friday, 21st Jan 2022) from $1.05 to $1.01. and has now fallen 10 days in a row. During the day the stock fluctuated 4.94% from a day low at $1.01 to a day high of $1.06. The price has fallen in 9 of the last 10 days and is down by -16.53% for this period. Volume has increased on the last day by 220 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 557 thousand shares were bought and sold for approximately $562.69 thousand.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.01 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -24.31% during the next 3 months and, with a 90% probability hold a price between $0.76 and $0.92 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

There are few to no technical positive signals at the moment. The ContraVir Pharmaceuticals Inc stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.11 and $1.20. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, December 22, 2021, and so far it has fallen -24.63%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). ContraVir Pharmaceuticals Inc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0499 between high and low, or 4.94%. For the last week, the stock has had a daily average volatility of 5.61%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is ContraVir Pharmaceuticals Inc stock A Buy?

ContraVir Pharmaceuticals Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.157

Strong Sell Candidate Unchanged

Predicted Opening Price for ContraVir Pharmaceuticals Inc of Monday, January 24, 2022

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price January 24, 2022 Current price
$1.03 $1.01 (Undervalued)

Remember To Visit Our YouTube Channel

Volatility and Risk
Daily Average Volatility: 5.61 %
Overall Risk: Very High High Medium Low Very Low
Volatility
5.61 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $1.22
Price: $1.01
No Support Found

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 1.08 6.59 %
1.06 4.70 %
1.05 3.53 %
Current price: 1.01
Support 1.01 -0.24 %
1.00 -1.41 %
0.98 -3.29 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 1.24 22.77 %
1.23 21.78 %
1.22 20.79 %
Current price 1.01
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT